Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treating the patient and not just the cancer: therapeutic burden in prostate cancer
Daniel E. Spratt, Neal D. Shore, Oliver Sartor, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 24, Iss. 3, pp. 647-661
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D. Davis, et al.
European Urology (2022) Vol. 83, Iss. 3, pp. 267-293
Open Access | Times Cited: 85
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study
Pablo Fernández‐Crehuet, Sofía Haselgruber, Alicia Padial-Gómez, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1029-1038
Open Access | Times Cited: 19
The Physical Activity and Cancer Control (PACC) framework: update on the evidence, guidelines, and future research priorities
Lin Yang, Kerry S. Courneya, Christine M. Friedenreich
British Journal of Cancer (2024) Vol. 131, Iss. 6, pp. 957-969
Open Access | Times Cited: 6
Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies
Rajeev K. Singla, Siva Sai Chandragiri, Hitesh Chopra, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
Follow-up of urolithiasis patients after treatment: an algorithm from the EAU Urolithiasis Panel
Riccardo Lombardo, Lazaros Tzelves, Robert Geraghty, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 5
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World Study
Sofía Haselgruber, Pablo Fernández-Crehuet-Serrano, M.D. Fernández-Ballesteros, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1875-1890
Open Access | Times Cited: 5
Dose-response association between cardiovascular health and mortality in cancer survivors
Rubén López‐Bueno, Lin Yang, Joaquín Calatayud, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102176-102176
Open Access | Times Cited: 10
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
Karim Fizazi, Neal D. Shore, Matthew R. Smith, et al.
European Journal of Cancer (2023) Vol. 192, pp. 113258-113258
Open Access | Times Cited: 9
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy
Brandon Lennep, Jesse Mack, Srinivasu Poondru, et al.
Drug Safety (2024) Vol. 47, Iss. 7, pp. 617-641
Open Access | Times Cited: 3
The association between polypharmacy and health-related quality of life among older adults with prostate cancer
Zongliang Yue, Xiangzhong Xue, Jingjing Qian
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 5, pp. 101772-101772
Closed Access | Times Cited: 3
Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study
Stefano Arcangeli, C. Chissotti, Federica Ferrario, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 5, pp. 1394-1403
Closed Access | Times Cited: 3
Exploring the interaction between immune cells in the prostate cancer microenvironment combining weighted correlation gene network analysis and single-cell sequencing: An integrated bioinformatics analysis
Danial Hashemi Karoii, Sobhan Bavandi, Melika Djamali, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer
Helen Y. Hougen, Nishwant Swami, Edward Christopher Dee, et al.
JCO Oncology Practice (2023) Vol. 19, Iss. 8, pp. 645-653
Open Access | Times Cited: 8
Comorbidity burden and health-related quality of life in men with advanced prostate cancer
Roberto M. Benzo, Patricia I. Moreno, Rina S. Fox, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 8
Open Access | Times Cited: 8
Anxiety and depression among cancer patients in Ethiopia: a systematic review and meta-analysis
Habtamu Geremew, Samuel Abdisa, Elyas Melaku Mazengia, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions
Konatham Teja Kumar Reddy, Karthickeyan Krishnan, P. Shanmugasundaram, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 6, pp. 830-845
Open Access | Times Cited: 2
Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
David Conde‐Estévez, I. Henrı́quez, Jesús Muñoz-Rodríguez, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 9, pp. 601-613
Open Access | Times Cited: 11
Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?
Ignacio F. San Francisco, Pablo A. Rojas, Juan Cristóbal Bravo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12508-12508
Open Access | Times Cited: 6
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention
Crystal S. Langlais, Yea‐Hung Chen, Erin L. Van Blarigan, et al.
Urologic Oncology Seminars and Original Investigations (2022) Vol. 41, Iss. 3, pp. 146.e1-146.e11
Open Access | Times Cited: 9
Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy
Christian Ruiz, Ilaria Alborelli, Massimilinao Manzo, et al.
Pathobiology (2023) Vol. 90, Iss. 6, pp. 400-408
Open Access | Times Cited: 4
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation
Paul Windisch, Ivo Becker, Hongjian Tang, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Identification of distinct symptom profiles in prostate cancer patients with cancer-related cognitive impairment undergoing androgen deprivation therapy: A latent class analysis
Yong-Cai Liu, Qin-Qing Yan, Jieru Zhou, et al.
Asia-Pacific Journal of Oncology Nursing (2024) Vol. 11, Iss. 6, pp. 100497-100497
Open Access | Times Cited: 1
Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy
Ramia J. Salloom, Iman M. Ahmad, Dania Z. Sahtout, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9195-9195
Open Access | Times Cited: 1
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: prediction of in vivo drug-drug interactions
Shichao Xiao, Hang Yin, Xin Lv, et al.
Chemico-Biological Interactions (2024), pp. 111246-111246
Closed Access | Times Cited: 1
Therapeutic burden in hidradenitis suppurativa: a cross‐sectional study of 557 patients
Sofía Haselgruber, Daniel Muñoz‐Barba, Francisco Javier León-Pérez, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top